Case presentation
Mid-aortic syndrome is a rare disorder characterised by narrowing of the thoracoabdominal aorta that most commonly presents with hypertension. This is typically diagnosed by angiography. Reference Rumman, Nickel and Matsuda-Abedini1
Here, a 30-month-old female presented with cardiomegaly and was diagnosed with dilated cardiomyopathy without identified infectious or genetic cause. Heart failure medications were initiated but, due to clinical deterioration, she was eventually listed for cardiac transplantation and underwent placement of a left ventricular assist device as a bridge. Post-operatively, her central venous pressure was elevated, raising concerns for right ventricular dysfunction. Transthoracic windows were limited, so a transesophageal echocardiogram was performed which demonstrated normal right ventricular function. Due to a newly noted upper to lower extremity blood pressure discrepancy, a non-standard transesophageal echocardiography view was performed by advancing the probe into the stomach and orienting it posteriorly at a 90-degree angle which demonstrated severe narrowing of the abdominal aorta with an obstructive Doppler pattern (Fig 1). Catheterisation revealed severe narrowing of the abdominal aorta and renal arteries (Fig 2) with a 50-mmHg peak-to-peak pressure gradient. The patient underwent polytetrafluoroethylene graft placement around the stenotic region with bilateral renal artery reconnection distal to the stenosis (Fig 3). She was subsequently decannulated from the device and later removed from the transplant list. Six years later, she continues to do well on oral heart failure medications.
In this first reported diagnosis of mid-aortic syndrome by transesophageal echocardiography, evaluation by non-standard imaging allowed for surgical repair and clinical recovery. This case also highlights that this rare diagnosis may be initially missed by transthoracic echocardiography as the abdominal aorta is not typically evaluated and should be considered with the presentation of both cardiomyopathy and hypertension.
Financial support
This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.
Conflicts of interest
None.